Cancers, Vol. 13, Pages 1943: PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification

Conclusions. Our study suggests that PD-L1 expression is an independent prognostic factor in patients with stage II/III colon cancer. Additionally, it successfully differentiates patients with better prognosis in the CMS2/CMS3 group and may prove significant for the clinical relevance of the CMS classification.

Source: Cancers - April 17, 2021 Category: Cancer & Oncology Authors: Pablo Azcue Ignacio Enc ío David Guerrero Setas Javier Suarez Alecha Arkaitz Galbete Mar ía Mercado Ruth Vera Maria Luisa Gomez-Dorronsoro Tags: Article Source Type: research